“Comparison Study of the Effect of Erlotinib as a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy” (2018) Ibn AL-Haitham Journal For Pure and Applied Sciences, 31(3), pp. 63–69. doi:10.30526/31.3.2011.